Search Results
Apr 30, 2026, 17:15 ET NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
the first quarter of 2025, we have updated our presentation of Adjusted EBITDA to separately disclose finance lease payments related to leases under ASC 842. We believe this update provides greater transparency into our operating performance.EBITDA and Adjusted EBITDA are not intended to serve
More news about: Nutex Health, Inc.
Apr 30, 2026, 16:01 ET ALLEGIANT TRAVEL COMPANY FIRST QUARTER 2026 FINANCIAL RESULTS
same rate as common stock. The basic and diluted earnings per share calculations for the periods presented reflect the two-class method mandated by ASC Topic 260, "Earnings Per Share." The two-class method adjusts both the net income and the shares used in the calculation. Application of the two-class
More news about: Allegiant Travel Company
Apr 30, 2026, 08:15 ET Silicom Reports Q1 2026 Results
(*) Adjustments related to share-based compensation expenses according to ASC topic 718 (SFAS 123 (R))
More news about: Silicom Ltd.
Apr 30, 2026, 07:00 ET International Paper Reports First Quarter 2026 Results
our business segments and assessing the performance of our business segments and is presented in our financial statement footnotes in accordance with ASC 280 - "Segment Reporting". First quarter 2026 net sales by business segment and operating profit (loss) by business segment compared with the fourth
More news about: International Paper
Apr 30, 2026, 06:02 ET Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant
provides surgeons with a simple, reproducible solution that integrates smoothly into existing surgical workflows. The system is purpose-built for the ASC setting and includes sterile-packaged instruments and implants to support procedural efficiency.Capitan Orthopedics, Inc. is backed by Genesis
More news about: Capitan Orthopedics, Inc.
Apr 29, 2026, 20:10 ET Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions
GLP-1R/GIPR dual peptide agonist and ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, ASC39, an eloralintide-like potent and amylin-selective oral small molecule amylin receptor agonist, and ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30 (GLP-1RA) and ASC39 (amylin RA), for chronic weight management.
More news about: Ascletis Pharma Inc.
Apr 29, 2026, 20:10 ET 歌禮將攜多個項目數據亮相美國糖尿病協會2026年度科學會議
展示詳情標題：ASC39：一款治療肥胖症的類似eloralintide、具有選擇性的強效口服小分子胰澱素受體激動劑 (ASC39: An Eloralintide-Like Selective and Potent Oral Small Molecule Amylin Receptor Agonist for the Treatment of Obesity)場次：最新突破壁報專場
More news about: 歌禮製藥有限公司
Apr 29, 2026, 16:15 ET MGM RESORTS INTERNATIONAL REPORTS FIRST QUARTER 2026 FINANCIAL AND OPERATING RESULTS
property transactions, net, net gain/loss related to equity investments for which we have elected the fair value option of ASC 825 and equity investments accounted for under ASC 321 for which there is a readily determinable fair value and net gain/loss related to our investments in debt securities, foreign
More news about: MGM Resorts International
Apr 29, 2026, 14:40 ET NJ Neurosurgeon First to Use Robotic-Assisted Technology in an Ambulatory Surgery Center
fellowship-trained neurosurgeon, has become the first provider in the world to perform robotic-assisted spine surgery in an ambulatory surgery center (ASC) using the eCential Robotics platform - a milestone that expands access to advanced surgical technology beyond the hospital setting.
More news about: Redefine Healthcare
Apr 29, 2026, 08:30 ET Ardmore Shipping Announces First Quarter 2026 Conference Call and Webcast
HAMILTON, Bermuda, April 29, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced that the Company plans to announce its first quarter earnings before the market opens on Thursday, May
More news about: Ardmore Shipping Corporation
Apr 29, 2026, 08:22 ET Ardmore Shipping Provides Update on Fleet Investment, Dividend Policy, and Vessel Sale
HAMILTON, Bermuda, April 29, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today provided the following update on capital allocation, vessel sale, and latest TCE guidance. Fleet InvestmentThe
More news about: Ardmore Shipping Corporation
Apr 29, 2026, 08:05 ET BillingPlatform Launches RevVenue to Help Finance Teams Manage Growing Revenue Recognition Complexity
New expert-led resource hub addresses mounting ASC 606 challenges as usage-based, AI-driven monetization models change how companies capture and recognize revenueDENVER, April 29, 2026 /PRNewswire/
More news about: BillingPlatform
Apr 28, 2026, 16:05 ET Welltower Reports First Quarter 2026 Results
include unamortized premiums/discounts, other fair value adjustments and financing lease liabilities. Excludes operating lease liabilities related to ASC 842 of $1,528,863,000 as of March 31, 2026.
More news about: Welltower Inc.
Apr 28, 2026, 12:33 ET Surgical Information Systems Appoints Division Presidents to Lead Software and Revenue Cycle Management Growth
empowered surgical providers to Operate Smart™ by delivering innovative ASC software and revenue cycle management services that drive clinical, financial, and operational success. SIS supports more than 2,900 ASCs with solutions spanning ASC management, clinical documentation, patient and physician engagement,
More news about: SURGICAL INFORMATION SYSTEMS
Apr 28, 2026, 09:00 ET RightRev Closes a Critical Finance‑Stack Gap with New Stripe Connector for Automated Revenue Recognition
platform enables businesses to automate revenue recognition, reporting, and compliance with revenue standards including ASC 606 and IFRS 15, as well as lessor accounting requirements under ASC 842 and IFRS 16, while simplifying data migration, implementation, and third-party integrations. With its AI-powered
More news about: RightRev
Apr 26, 2026, 20:10 ET Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
GLP-1R/GIPR dual peptide agonist and ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist, and ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30 and ASC39, for chronic weight management. Ascletis
More news about: Ascletis Pharma Inc.
Apr 26, 2026, 20:10 ET 歌禮宣布口服小分子GLP-1R激動劑ASC30治療糖尿病的美國II期研究完成入組
「ASC30在肥胖或超重受試者的美國II期研究中展現出的療效和耐受性，證明了其有望成為治療肥胖症的同類最佳口服小分子GLP-1藥物，」歌禮創始人、董事會主席兼首席執行官吳勁梓博士表示，「將ASC30的臨床開發拓展至龐大的糖尿病治療市場，是合乎邏輯的下一步戰略，為我們提供了另一個機遇，以彰顯ASC30有望為患者提供同類最佳的每日一次口服療法選擇。我們期待在2026年第三季度分享在糖尿病受試者中開展的II期研究的頂線數據。」吳博士補充道：「基於2025年12月公布的在肥胖或超重受試者中開展的ASC
More news about: 歌禮製藥有限公司
Apr 23, 2026, 08:00 ET Heritage Financial Announces First Quarter 2026 Results and Declares Regular Cash Dividend of $0.24 Per Share
Deteriorated ("PCD"), loans that have experienced more than insignificant credit deterioration since origination, or Purchased Seasoned Loans ("PSLs"). Per ASC 326-20-30-16, all loans that are acquired as part of a business combination accounted for using the acquisition method in accordance with Subtopic 805-20
More news about: Heritage Financial Corporation
Apr 22, 2026, 09:00 ET Whitley Penn Strengthens Leadership with Valuation Partner
has extensive experience leading engagements involving purchase price allocations (ASC 805), goodwill and long-lived asset impairments (ASC 350/360), stock-based compensation (ASC 718), and fair value measurements (ASC 820). He also advises clients on valuation issues in M&A transactions, tax planning,
More news about: Whitley Penn
Apr 21, 2026, 07:00 ET DolCas Biotech: Beauty-From-Within Collagen Tripeptide Gets New Delivery Format
opportunities for applications in joint health, sports nutrition, and healthy aging formulations.Morikol® is produced from the upscaled skin of ASC-certified freshwater tilapia via a specialized enzymatic hydrolysis process custom designed to generate bioactive collagen tripeptides. This proprietary
More news about: DolCas Biotech
Apr 20, 2026, 08:32 ET Newest MISHA® Knee System Used for First Time in the State of Indiana
in Indiana to utilize the newest generation of the MISHA Knee System and performed the surgery at Lakeshore Surgicare, an ambulatory surgery center (ASC) located in Chesterton, Indiana."With the MISHA Knee System, we offer patients a joint-preserving solution designed to reduce pain and improve
More news about: Lakeshore Bone & Joint Institute
Apr 17, 2026, 17:00 ET ASC Ortho Management Company, LLC d/b/a Aligned Orthopedic Partners Provides Notice Following Data Security Incident
BETHESDA, Md., April 17, 2026 /PRNewswire/ -- ASC Ortho Management Company, LLC d/b/a Aligned Orthopedic Partners ("Aligned Orthopedic") recently notified potentially impacted individuals of a data security incident that may
More news about: ASC Ortho Management Company, LLC d/b/a Aligned Orthopedic Partners
Apr 16, 2026, 09:00 ET GTIS Partners Acquires 116-Acre Site for Industrial Development in Tampa, Florida MSA
www.gtispartners.com.Media ContactsMary Beth Grover / Keely GispanASC Advisors(203) [email protected] /
More news about: GTIS Partners
Apr 15, 2026, 09:00 ET National Safety Council, Boeing Announce $2.3M Multi-Year Commitment to Expand Veteran Safety Scholarship
the next step in their careers." The ASC Scholarship for Veterans was created to strengthen and diversify the pipeline of skilled workers entering the EHS profession. Scholarship recipients receive: Free enrollment in the ASC program, a 12-day training series that builds foundational
More news about: National Safety Council
Apr 08, 2026, 09:00 ET GTIS Partners and Hovnanian Enterprises Announce Closing of $200 Million Homebuilding Joint Venture Portfolio Bringing Total Portfolio To $1.5 Billion
website at www.khov.com.Media ContactsMary Beth Grover / Keely GispanASC Advisors(203) [email protected] /
More news about: GTIS Partners